DRI Healthcare Trust (TSX:DHT.UN)
Canada · Delayed Price · Currency is CAD 18.01
+0.38 (2.16%)
Aug 10, 2026, 4:00 PM EST
DRI Healthcare Trust Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 199.32 | 188.92 | 184.71 | 158.91 | 87.27 | 79.86 |
Other Revenue | 1.28 | 2.89 | 2.27 | 7.37 | 5.76 | 1.91 |
| 200.6 | 191.81 | 186.99 | 166.28 | 93.03 | 81.77 | |
Revenue Growth | 5.62% | 2.58% | 12.45% | 78.73% | 13.78% | - |
Gross Profit | 200.6 | 191.81 | 186.99 | 166.28 | 93.03 | 81.77 |
Selling, General & Admin | 6.82 | 14.01 | 20.29 | 49.64 | 9.19 | 9.6 |
Other Operating Expenses | 5.45 | 10.39 | 7.86 | 4.11 | 4.29 | 5.41 |
Operating Expenses | 131.77 | 138.34 | 140.02 | 146.62 | 74.2 | 57.33 |
Operating Income | 68.83 | 53.47 | 46.97 | 19.66 | 18.83 | 24.44 |
Interest Expense | -40.72 | -39.7 | -34.91 | -26.5 | -6.63 | -2.24 |
Currency Exchange Gain (Loss) | 3.27 | - | - | - | - | 0.08 |
Other Non Operating Income (Expenses) | -1.51 | - | -1.58 | -2.57 | -1.25 | -0.72 |
EBT Excluding Unusual Items | 29.87 | 13.78 | 10.49 | -9.41 | 10.95 | 21.56 |
Gain (Loss) on Sale of Investments | 2.14 | 2.03 | -0.77 | - | - | - |
Gain (Loss) on Sale of Assets | - | - | - | 110.12 | - | - |
Asset Writedown | -16.96 | -18.62 | -15.26 | -9.22 | - | - |
Other Unusual Items | -57.01 | -48.18 | 2.18 | - | - | - |
Pretax Income | -41.95 | -51 | -3.36 | 91.5 | 10.95 | 21.56 |
Income Tax Expense | 2.1 | -0.53 | - | - | - | - |
Net Income | -44.06 | -50.47 | -3.36 | 91.5 | 10.95 | 21.56 |
Net Income to Common | -44.06 | -50.47 | -3.36 | 91.5 | 10.95 | 21.56 |
Net Income Growth | - | - | - | 735.35% | -49.20% | - |
Shares Outstanding (Basic) | 56 | 56 | 56 | 44 | 39 | 35 |
Shares Outstanding (Diluted) | 56 | 56 | 56 | 45 | 39 | 35 |
Shares Change | -0.74% | -1.07% | 26.26% | 15.63% | 11.36% | - |
EPS (Basic) | -0.79 | -0.91 | -0.06 | 2.06 | 0.28 | 0.62 |
EPS (Diluted) | -0.80 | -0.91 | -0.06 | 2.05 | 0.28 | 0.62 |
EPS Growth | - | - | - | 632.14% | -54.84% | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 120.43 | 108.96 | 155.41 | 76.38 | 76.86 | 91.86 |
Free Cash Flow Per Share | 2.16 | 1.96 | 2.76 | 1.71 | 1.99 | 2.65 |
Dividend Per Share | 0.200 | 0.400 | 0.340 | 0.300 | 0.300 | 0.167 |
Dividend Growth | -45.95% | 17.65% | 13.33% | 0% | 79.96% | - |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Operating Margin | 34.31% | 27.88% | 25.12% | 11.83% | 20.24% | 29.89% |
Profit Margin | -21.96% | -26.31% | -1.80% | 55.03% | 11.77% | 26.37% |
Free Cash Flow Margin | 60.03% | 56.81% | 83.12% | 45.94% | 82.62% | 112.35% |
EBITDA | 171.89 | 155.44 | 149.83 | 106.65 | 78.07 | 66.28 |
EBITDA Margin | 85.69% | 81.03% | 80.13% | 64.14% | 83.91% | 81.05% |
D&A For EBITDA | 103.06 | 101.97 | 102.87 | 86.98 | 59.23 | 41.84 |
EBIT | 68.83 | 53.47 | 46.97 | 19.66 | 18.83 | 24.44 |
EBIT Margin | 34.31% | 27.88% | 25.12% | 11.83% | 20.24% | 29.89% |
Revenue as Reported | 209.15 | 198.59 | 186.75 | 166.28 | 93.03 | 81.77 |